From the Food and Drug Administration.
Henney
J E
JE
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000627:therapeutic use*; D002047:Buprenorphine / Q000627:therapeutic use*; D002648:Child; D004338:Drug Combinations; D004335:Drug and Narcotic Control; D015507:Drugs, Investigational; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy; D061466:Lopinavir; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D010087:Oxides / Q000627:therapeutic use*; D011744:Pyrimidinones / Q000627:therapeutic use*; D011957:Receptors, Opioid / Q000819:agonists*; D019438:Ritonavir / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D001152:Arsenicals; D004338:Drug Combinations; D015507:Drugs, Investigational; D017320:HIV Protease Inhibitors; D010087:Oxides; D011744:Pyrimidinones; D011957:Receptors, Opioid; D061466:Lopinavir; D002047:Buprenorphine; D019438:Ritonavir; D000077237:Arsenic Trioxide